- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Kinesis Pharma B.V.
Total 195 results
-
Kynexis B.V.ParexelRecruitingSchizophrenia | Cognitive DysfunctionUnited States
-
Diakron PharmaceuticalsDrug Research Unit Ghent, Ghent, Belgium; Kinesis Pharma B.V.TerminatedDeep Vein Thrombosis Leg | Stroke (in Patients With Atrial Fibrillation)Belgium
-
Genesis Pharma S.A.Completed
-
Genesis Pharma S.A.Completed
-
Genesis Pharma S.A.CompletedRelapse/Refractory Multiple MyelomaGreece
-
Genesis Pharma S.A.Completed
-
Genesis Pharma CNS & SpecialtyCompleted
-
Genesis Pharma S.A.CelgeneCompletedModerate Plaque PsoriasisGreece
-
Genesis Pharma CNS & SpecialtyCompletedMultiple SclerosisGreece
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor OveractivityBelgium, Denmark, Norway, Poland, Serbia
-
Astellas Pharma Europe B.V.CompletedHealthy VolunteersUnited States
-
Astellas Pharma Europe B.V.CompletedInterstitial Cystitis | Bladder Pain SyndromeSpain, Russian Federation, Belgium, Czechia, Germany, Hungary, Latvia, Netherlands, Poland, United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Type 2 Diabetes Mellitus (T2DM) | Chronic Kidney Disease (CKD) | Pharmacokinetics of ASP8232 | Pharmacodynamics of ASP8232Bulgaria, Moldova, Republic of, Romania
-
Astellas Pharma Europe B.V.CompletedDiabetes Mellitus | Diabetic Macular EdemaUnited States
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesBelgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
-
Astellas Pharma Europe B.V.CompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaBelgium, Italy, France, Austria, United Kingdom, Netherlands, Poland, Slovakia, Belarus, Germany, Czechia
-
Astellas Pharma Europe B.V.CompletedType 2 Diabetes MellitusGermany
-
Astellas Pharma Europe B.V.CompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaBelgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, Czech Republic, Germany, Spain, Sweden, United Kingdom
-
Astellas Pharma Europe B.V.CompletedAdvanced Prostate CarcinomaRussian Federation
-
Astellas Pharma Europe B.V.CompletedHealthy VolunteersUnited Kingdom
-
Astellas Pharma International B.V.TerminatedChronic Lymphocytic Leukaemia (CLL) | Indolent Non Hodgkin's Lymphoma (iNHL)Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates
-
Astellas Pharma Europe B.V.CompletedVenous Thromboembolism | Arthroplasty, Replacement, HipDenmark, Spain, United States, Austria, Colombia, Russian Federation, India, Italy, United Kingdom, Germany, Hungary, Estonia, Romania, South Africa, Israel, Poland, Sweden, Canada, Australia, Lithuania, Ukraine, Latvia, Finland, Brazil, Slovak... and more
-
Astellas Pharma Europe B.V.CompletedHealthy SubjectsUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedPharmacokinetics of ASP1707 | Pharmacodynamics of ASP1707France
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Urinary Incontinence | Urge IncontinenceFrance, Belgium, Spain, Turkey, Australia, Russian Federation, Hungary, Italy, Netherlands, Poland, Czech Republic
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Drug-Drug Interaction (DDI)France
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP3652United Kingdom
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive BladderPoland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of YM178Netherlands
-
Astellas Pharma Europe B.V.CompletedA Study to Find Out How YM150 is Absorbed Into and Eliminated From the Body in Healthy Male SubjectsHealthy Male Subjects | PharmacokineticsNetherlands
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedThromboembolismItaly, Spain, Sweden, Austria, Denmark, Russian Federation, Poland, Bosnia and Herzegovina, Serbia, Norway, Latvia, Finland, Lithuania, Czech Republic, Germany, Slovakia, Greece
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Pharmacodynamics | SafetyNetherlands
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityBelgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Neurogenic Detrusor OveractivityDenmark, Poland
-
Astellas Pharma Europe B.V.CompletedOsteoarthritis of the Knee | Chronic Lower Back PainBelgium, Czechia, Germany, Hungary, Spain, United Kingdom
-
Astellas Pharma Europe B.V.CompletedEndometriosisBelgium, Bulgaria, Germany, Hungary, Japan, Poland, Romania, Ukraine, United Kingdom
-
Astellas Pharma Europe B.V.CompletedPediatric | Neurogenic Detrusor OveractivityUnited States, Belgium, Korea, Republic of, Philippines, Poland, United Kingdom
-
Astellas Pharma Europe B.V.CompletedType 2 Diabetes | Chronic Kidney DiseaseSpain, Czechia, Denmark, Germany, Hungary, Italy, Netherlands, Poland, United Kingdom
-
Astellas Pharma Europe B.V.CompletedType 2 Diabetes MellitusRussian Federation
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesUnited States, Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands and more
-
Astellas Pharma Europe B.V.CompletedNeuropathic Pain | Post-Herpetic Neuralgia (PHN) | Painful Diabetic Peripheral Neuropathy (PDPN)Czechia, Germany, Poland, United Kingdom
-
Astellas Pharma Europe B.V.Terminated
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP6294United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy VolunteersUnited Kingdom, Germany
-
Astellas Pharma Europe B.V.TerminatedHealthy Subjects | Pharmacokinetics of ASP2205United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy | Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Phase 1Netherlands
-
Astellas Pharma Europe B.V.CompletedHealthy Volunteers | Pharmacokinetics of ASP7962United Kingdom
-
Astellas Pharma Europe B.V.TerminatedClostridium DifficileFrance, Germany, Netherlands, Spain